232 related articles for article (PubMed ID: 28380463)
1. Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis.
Deng X; Tu Z; Xiong M; Tembo K; Zhou L; Liu P; Pan S; Xiong J; Yang X; Leng J; Zhang Q; Xiao R; Zhang Q
Oncotarget; 2017 Jun; 8(24):39033-39047. PubMed ID: 28380463
[TBL] [Abstract][Full Text] [Related]
2. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
[TBL] [Abstract][Full Text] [Related]
3. CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma
Chai S; Wen Z; Zhang R; Bai Y; Liu J; Li J; Kongling W; Chen W; Wang F; Gao L
PeerJ; 2022; 10():e13844. PubMed ID: 36003306
[TBL] [Abstract][Full Text] [Related]
4. Daam1 activates RhoA to regulate Wnt5a‑induced glioblastoma cell invasion.
Liu G; Yan T; Li X; Sun J; Zhang B; Wang H; Zhu Y
Oncol Rep; 2018 Feb; 39(2):465-472. PubMed ID: 29207169
[TBL] [Abstract][Full Text] [Related]
5. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
[TBL] [Abstract][Full Text] [Related]
6. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9.
Zhou B; Leng J; Hu M; Zhang L; Wang Z; Liu D; Tong X; Yu B; Hu Y; Deng C; Liu Y; Zhang Q
Leuk Res; 2010 Jun; 34(6):769-76. PubMed ID: 20036004
[TBL] [Abstract][Full Text] [Related]
7. Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.
Zhang L; Xiao R; Xiong J; Leng J; Ehtisham A; Hu Y; Ding Q; Xu H; Liu S; Wang J; Tang DG; Zhang Q
PLoS One; 2013; 8(1):e52384. PubMed ID: 23326330
[TBL] [Abstract][Full Text] [Related]
8. Role of Rho-ROCK signaling in MOLT4 cells metastasis induced by CCL25.
Zhang L; Yu B; Hu M; Wang Z; Liu D; Tong X; Leng J; Zhou B; Hu Y; Wu R; Ding Q; Zhang Q
Leuk Res; 2011 Jan; 35(1):103-9. PubMed ID: 20855113
[TBL] [Abstract][Full Text] [Related]
9. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.
Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R
DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282
[TBL] [Abstract][Full Text] [Related]
10. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
[TBL] [Abstract][Full Text] [Related]
11. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
12. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.
Johnson-Holiday C; Singh R; Johnson EL; Grizzle WE; Lillard JW; Singh S
World J Surg Oncol; 2011 May; 9():46. PubMed ID: 21539750
[TBL] [Abstract][Full Text] [Related]
13. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
[TBL] [Abstract][Full Text] [Related]
14. Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin.
Hu Y; Zhang L; Wu R; Han R; Jia Y; Jiang Z; Cheng M; Gan J; Tao X; Zhang Q
Leuk Res; 2011 Sep; 35(9):1254-60. PubMed ID: 21295855
[TBL] [Abstract][Full Text] [Related]
15. Wnt5a/ROR1 activates DAAM1 and promotes the migration in osteosarcoma cells.
Dai B; Shen Y; Yan T; Zhang A
Oncol Rep; 2020 Feb; 43(2):601-608. PubMed ID: 31894282
[TBL] [Abstract][Full Text] [Related]
16. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
Chen HJ; Edwards R; Tucci S; Bu P; Milsom J; Lee S; Edelmann W; Gümüs ZH; Shen X; Lipkin S
J Clin Invest; 2012 Sep; 122(9):3184-96. PubMed ID: 22863617
[TBL] [Abstract][Full Text] [Related]
17. WNT5A: a motility-promoting factor in Hodgkin lymphoma.
Linke F; Zaunig S; Nietert MM; von Bonin F; Lutz S; Dullin C; Janovská P; Beissbarth T; Alves F; Klapper W; Bryja V; Pukrop T; Trümper L; Wilting J; Kube D
Oncogene; 2017 Jan; 36(1):13-23. PubMed ID: 27270428
[TBL] [Abstract][Full Text] [Related]
18. CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation.
Qiuping Z; Jei X; Youxin J; Wei J; Chun L; Jin W; Qun W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Kejian Z; Zhimin S; Qun L; Junyan L; Jinquan T
Cancer Res; 2004 Oct; 64(20):7579-87. PubMed ID: 15492285
[TBL] [Abstract][Full Text] [Related]
19. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
[TBL] [Abstract][Full Text] [Related]
20. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
